Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



SILVERNAIL LAUREN P Create: Alert

All | News | Filings
Date FiledTypeDescription
09/19/2022 4 SILVERNAIL LAUREN P (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.
Txns: Granted 20,335 options to buy @ $1.62, valued at $32.9k
09/19/2022 3 SILVERNAIL LAUREN P (Director) has filed a Form 3 on Harpoon Therapeutics, Inc.
05/18/2022 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Sold 16,189 shares @ $13.9202, valued at $225.4k
Sold 52,015 shares @ $12.42, valued at $646k
03/10/2022 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Sold 10,192 shares @ $9.7254, valued at $99.1k
01/26/2022 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Granted 53,571 shares @ $0
Granted 77,640 options to buy @ $5.46, valued at $423.9k
08/12/2021 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
08/12/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/26/2021 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Sold 2,699 shares @ $7.46, valued at $20.1k
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2020 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Granted 26,000 shares @ $0
Granted 45,000 options to buy @ $10.19, valued at $458.6k
05/31/2019 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Sold 2,612 shares @ $13.5345, valued at $35.4k
01/25/2019 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Granted 45,000 options to buy @ $16.19, valued at $728.6k
05/31/2018 4 SILVERNAIL LAUREN P (See Remarks) has filed a Form 4 on Evolus, Inc.
Txns: Granted 30,000 shares @ $0
Granted 200,000 options to buy @ $22.44, valued at $4.5M
05/31/2018 3 SILVERNAIL LAUREN P (See Remarks) has filed a Form 3 on Evolus, Inc.
05/24/2018 4 SILVERNAIL LAUREN P (CFO & CBO) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 2,874 shares @ $30.2451, valued at $86.9k
03/23/2018 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 3,431 shares @ $30.8478, valued at $105.8k
03/15/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2018 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 10,000 shares @ $31.5, valued at $315k
Sold 10,000 shares @ $32.5, valued at $325k
Exercised 10,000 options to buy @ $8.7, valued at $87k
Exercised 10,000 options to buy @ $8.7, valued at $87k
02/16/2018 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,136 shares @ $31.75, valued at $36.1k
02/09/2018 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Granted 8,125 shares @ $0
Granted 48,750 options to buy @ $29.15, valued at $1.4M
01/30/2018 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 990 shares @ $33.5, valued at $33.2k
01/03/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Exercised 17,506 options to buy @ $8.7, valued at $152.3k
11/09/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 10,000 shares @ $26.8267, valued at $268.3k
Exercised 10,000 options to buy @ $8.7, valued at $87k
10/16/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 11,164 shares @ $26.6714, valued at $297.8k
07/05/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Acquired 604 shares @ $18.3175, valued at $11.1k
05/31/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Exercised 23,000 options to buy @ $8.7, valued at $200.1k
05/24/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Sold 1,793 shares @ $20.1964, valued at $36.2k
03/17/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/30/2017 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
07/05/2016 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Acquired 749 shares @ $11.56, valued at $8.7k
05/23/2016 4 SILVERNAIL LAUREN P (CFO, CBO & Secretary) has filed a Form 4 on Revance Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,753 shares @ $17.11, valued at $30k
02/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy